The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Board Change

8 Jan 2016 07:00

RNS Number : 2150L
Sopheon PLC
08 January 2016
 

For Immediate Release

 

 

SOPHEON PLC

("Sopheon" or the "Company")

 

TRADING UPDATE

BOARD CHANGE

 

 

Sopheon plc, the international provider of software and services for complete Enterprise Innovation Performance solutions, is pleased to announce a trading update for the Group's performance in 2015.

 

In our interim report issued in August 2015, we highlighted a positive shift in the momentum of the business and we are pleased to report that this translated into strong performance for the second half of the year. As a consequence, we expect that reported revenues for the year ended 31 December 2015 will be comfortably in line with current market expectations, and that EBITDA and pre-tax profits will exceed current market expectations.

 

Financial expectations noted above are subject to the completion of year-end financial close and audit processes. Sopheon intends to issue its results for the year ended 31 December 2015 on 17 March 2016.

 

Finally and with much sadness, we also announce that Dr. Bernard Al, a non-executive director, passed away over the holiday period. Bernard served on the Sopheon board from 2001, and made an important contribution to guiding the Company's development during that time. He will be greatly missed, and the board offers its sincerest condolences to his family.

 

 

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1276 919 560

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Ed Frisby/Carl Holmes (corporate finance)

Mia Gardener (corporate broking)

finnCap

+ 44 (0) 20 7220 0500

 

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKODBOBKDCDK
Date   Source Headline
24th Jan 20067:01 amRNSContract Win
10th Jan 20067:00 amPRNTrading Update
23rd Dec 20057:00 amPRNLoan Conversion
16th Dec 20057:00 amPRNDisposal
18th Nov 20051:40 pmRNSAdditional Listing
20th Oct 20056:00 amPRNTHIRD QUARTER TRADING UPDATE
1st Sep 20056:00 amPRNInterim Results
26th Aug 200510:00 amPRNAdditional Listing
24th Aug 200510:00 amPRNNotice of Results
15th Jul 20056:00 amPRNTrading Update
30th Jun 20054:00 pmPRNAdditional Listing
17th Jun 20052:02 pmPRNResult of AGM
17th Jun 20056:00 amPRNAGM Statement
31st May 200511:45 amPRNAdditional Listing
24th May 20056:00 amPRNProduct Launch
6th May 200512:00 pmPRNHolding(s) in Company
6th May 200512:00 pmPRNAdditional Listing
3rd May 20057:01 amRNSContract Win
15th Apr 20059:30 amPRNDirector Shareholding
6th Apr 20059:30 amPRNAdditional Listing and Directors Shareholdings
5th Apr 20056:00 amPRNPreliminary Results
30th Mar 20059:30 amPRNNotice of Results
7th Mar 20057:00 amPRNCadbury Schweppes
19th Jan 20057:00 amPRNContract Win
18th Jan 20057:00 amPRNTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.